Us Congress 2023-2024 Regular Session

Us Congress House of Representatives 2023 Bills & Legislation (Page 110)

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB197

Introduced
1/9/23  
Refer
1/9/23  
Rural Telehealth Expansion Act This bill expands coverage of telehealth services under Medicare to include store-and-forward technologies (in which information is sent to providers and reviewed at a later time, rather than through a real-time interaction). Currently, coverage is limited to federal demonstration programs in Alaska and Hawaii.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1970

Introduced
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Energy Employees Occupational Illness Compensation Program for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1971

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Global Health for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1972

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Public Health Preparendness and Response for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1973

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Buildings and Facilities for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1974

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention-Wide Activities and Program Support for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1975

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Cancer Institute for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1976

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Heart, Lung, and Blood Institute for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1977

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institutes of Dental and Craniofacial Research for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1978

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1979

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Intitute of Neurological Disorders and Stroke for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB198

Introduced
2/27/23  
Drug Pricing Transparency and Accountability Act This bill establishes a two-year moratorium on allowing new, non-rural hospitals and associated child sites to participate in the 340B drug pricing program; during the moratorium, the Department of Health and Human Services must issue regulations with specified program eligibility standards. The bill also requires additional reporting relating to program participation, eligibility, and costs.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1980

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Disease for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1981

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of General Medical Science for fiscal year 2024.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1982

Introduced
3/29/23  
Refer
3/29/23  
To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for fiscal year 2024.

Research Filters

States
Terms / Sessions
Chamber Records